INTRANASAL DEXMEDETOMIDINE AS CONSCIOUS SEDATION IN SURGICAL EXTRACTION OF IMPACTED TEETH
Main Article Content
Keywords
Conscious Sedation, Intranasal, Dexmedetomidine, Mandibular Third Molars, Surgical Removal
Abstract
BACKGROUND & OBJECTIVES
The handling of a patient's worry and concern before surgery has long been an important aspect of patient care. Conscious sedation techniques can considerably reduce the need for general anaesthesia for minor oral surgical operations. Among different drugs used for conscious sedation, Dexmedetomidine is chosen because it causes less respiratory depression, easy arousal of the patient and analgesic sparing properties. Use of Intranasal medications for dental procedures is easy and effective. The nasal Atomiser device delivers intranasal medication in a fine mist which ensures the exact dose and volume delivered, enhances absorption improves bioavailability for fast and effective drug delivery.
METHOD
The study was carried out in 10 patients. Patients with impacted mandibular third molars were chosen for the study. All the patients were administered intranasal Dexmedetomidine, through Mucosal Automiser Device 30 mins before the procedure. Patients were evaluated for Sedation and Pain, Sedation at 30 mins and 60 mins intra operatively using Observer’s Assessment of Alertness/Sedation (OAA/ S) and Pain at baseline and 30 mins and 60 mins intra operatively using Visual Analogue Scale. Patient’s vitals such as Blood Pressure, Heart Rate and Oxygen Saturation was monitored continuously.
RESULTS
All cases showed significant sedation (p<0.05) with OAA/S score at 30 mins intra-operatively. In two out of ten patients, VAS score was reduced at 60mins.
CONCLUSION
This study aimed to evaluate the efficacy of Intranasal Dexmedetomidine for achieving conscious sedation in patients. Significant Sedation (p<0.05) was achieved at 30mins intraoperatively. Hence we conclude by saying that, Dexmedetomidine given intranasally is a non-invasive and effective way to achieve sedation in patients undergoing procedures under local anesthesia in order to reduce the anxiety of the patient related to the procedure.
References
2. Mantz J, Josserand J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol 2011;28(1):3-6.
3. Harris M, Chung F. Complications of general anesthesia. Clinics in plastic surgery. 2013;40(4):503-13.
4. Kapur A, Kapur V. Conscious sedation in dentistry. Annals of Maxillofacial Surgery 2018;8(2):320.
5. Lee S. Dexmedetomidine: present and future directions. Korean Journal of Anesthesiology 2019;72(4):323-30
6. Santosh P. Impacted mandibular third molars: Review of literature and a proposal of a combined clinical and radiological classification. Annals of Medical and Health Sciences Research 2015;5(4):229-34.
7. Nooh N, Sheta SA, Abdullah WA, Abdelhalim AA. Intranasal atomized dexmedetomidine for sedation during third molar extraction. International Journal of Oral and Maxillofacial Surgery 2013;42(7):857-62.
8. Shetty SK, Aggarwal G. Efficacy of intranasal dexmedetomidine for conscious sedation in patients undergoing surgical removal of impacted third molar: a double-blind split mouth study. Journal of maxillofacial and Oral Surgery 2016;15:512-6.
9. Cheung CW, Ng KF, Liu J, Yuen MY, Ho MH, Irwin MG. Analgesic and sedative effects of intranasal dexmedetomidine in third molar surgery under local anaesthesia. British Journal of Anaesthesia. 2011;107(3):430-7.
10. Ryu DS, Lee DW, Choi SC, Oh IH, Sedation protocol using dexmedetomidine for third molar extraction. Journal of Oral and Maxillofacial Surgery 2016;74(5):926-e1.
11. Bhargavi M, Sarath GS, Surana P, Dhull KS, Shaikh M, Rajan M. Efficacy of intranasal atomized dexmedetomidine for sedation in surgical removal of impacted mandibular third molars: a prospective study. Cureus 2023;15(3):e36721.